Skip to main content

Advertisement

Log in

Association of systemic immune-inflammation index and systemic inflammation response index with chronic kidney disease: observational study of 40,937 adults

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Background

Chronic kidney disease (CKD) is linked to immunity and inflammation. Systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) are novel measures for gauging an individual’s systemic inflammatory activity. We aim to investigate the potential associations between them.

Methods

This study encompassed a cohort of 40,937 adults from the National Health and Nutrition Examination Survey (NHANES) 1999–2018. SII and SIRI were log2-transformed before conducting regression analysis, considering that these inflammatory markers were right skewed distributed. Weighted logistic regression models assessed the association of log2-SII and log2-SIRI levels with CKD prevalence. Weighted Cox regression models were utilized to estimate the risk of death. Subgroup analyses were performed to further clarify the effects of other covariates on the associations. Sensitivity analyses were performed to assess the robustness of our results.

Results

6986 participants with CKD were recorded, and 2818 patients died during a mean follow-up time of 100 months. After adjusting for all covariates, the highest level of log2-SII increased the CKD incidence (odds ratio [OR]: 1.47, 95% confidence intervals [CI]: 1.32–1.65, P < 0.001), as well as log2-SIRI (OR: 1.79, 95% CI 1.60–2.01, P < 0.001) when compared with the lowest level reference group. The highest level of log2-SII significantly increased all-cause mortality (hazard risk [HR]: 1.29; 95% CI 1.13–1.48, P < 0.001), cardiovascular mortality (HR: 1.61, 95% CI 1.25–2.09, P < 0.001), and hypertension mortality (HR: 1.73, 95% CI 1.23–2.42, P = 0.001) in CKD patients. Additionally, the positive associations were also found between log2-SIRI and all cause (HR: 1.54, 95% CI 1.35–1.76, P < 0.001), cardiovascular (HR: 1.90, 95% CI 1.38–2.60, P < 0.001), and hypertension mortality (HR: 2.15, 95% CI 1.56–2.94, P < 0.001). Subgroup analyses unveiled variations in these effects among different populations.

Conclusion

There existed a substantial association of SII and SIRI levels with CKD prevalence, as well as mortality in patients with CKD in the U.S. population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The original data used in this study are nationally representative and publicly available, and can be directly obtained through application to NHANES, which is an ongoing periodic survey of a nationally representative sample of the U.S. noninstitutionalized civilian population using a complex multistage whole-population probability sampling strategy. More details about the survey can be found on the publicly available NHANES website.

References

  1. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11.

    Article  Google Scholar 

  2. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis. 2018;25(2):121–32.

    Article  PubMed  Google Scholar 

  4. Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74(1):120–31.

    Article  PubMed  Google Scholar 

  5. Malta D, Petersen KS, Johnson C, Trieu K, Rae S, Jefferson K, et al. High sodium intake increases blood pressure and risk of kidney disease. From the science of salt: a regularly updated systematic review of salt and health outcomes (August 2016 to March 2017). J Clin Hypertens. 2018;20(12):1654–65.

    Article  CAS  Google Scholar 

  6. Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1–3):84–92.

    Article  CAS  PubMed  Google Scholar 

  7. Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol. 2014;10(9):493–503.

    Article  CAS  PubMed  Google Scholar 

  8. Ebert T, Neytchev O, Witasp A, Kublickiene K, Stenvinkel P, Shiels PG. Inflammation and oxidative stress in chronic kidney disease and dialysis patients. Antioxid Redox Signal. 2021;35(17):1426–48.

    Article  CAS  PubMed  Google Scholar 

  9. Dziedzic EA, Gąsior JS, Tuzimek A, Paleczny J, Junka A, Dąbrowski M, et al. Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23(17):9553.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Liu B, Wang J, Li YY, Li KP, Zhang Q. The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999–2018. Arthritis Res Ther. 2023;25(1):34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Luo J, Qin X, Zhang X, Zhang Y, Yuan F, Shi W, et al. Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registry. Cardiovasc Diabetol. 2024;23(1):41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Pacheco-Barcia V, Mondéjar Solís R, France T, Asselah J, Donnay O, Zogopoulos G, et al. A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pancreatology. 2020;20(2):254–64.

    Article  CAS  PubMed  Google Scholar 

  13. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F. Inflammation and pregnancy. Reprod Sci. 2009;16(2):206–15.

    Article  CAS  PubMed  Google Scholar 

  14. Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DR. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4s):S1–276.

    Article  Google Scholar 

  15. Delgado C, Baweja M, Crews DC, Eneanya ND, Gadegbeku CA, Inker LA, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. J Am Soc Nephrol. 2021;32(12):2994–3015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Feng C, Wang H, Lu N, Chen T, He H, Lu Y, et al. Log-transformation and its implications for data analysis. Shanghai Arch Psychiatry. 2014;26(2):105–9.

    PubMed  PubMed Central  Google Scholar 

  17. Curran-Everett D. Explorations in statistics: the log transformation. Adv Physiol Educ. 2018;42(2):343–7.

    Article  PubMed  Google Scholar 

  18. Li J, Liu Z, Pu Y, Dai H, Peng F. Association between dietary vitamin E intake and chronic kidney disease events in US adults: a cross-sectional study from NHANES 2009–2016. Clin Kidney J. 2023;16(12):2559–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Mazidi M, Gao HK, Kengne AP. Food patterns are associated with likelihood of CKD in US adults. Sci Rep. 2018;8(1):10696.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Weir CB, Jan A. BMI classification percentile and cut off points. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Arif Jan declares no relevant financial relationships with ineligible companies. StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC.; 2024.

  21. Lai W, Xie Y, Zhao X, Xu X, Yu S, Lu H, et al. Elevated systemic immune inflammation level increases the risk of total and cause-specific mortality among patients with chronic kidney disease: a large multi-center longitudinal study. Inflamm Res. 2023;72(1):149–58.

    Article  CAS  PubMed  Google Scholar 

  22. Mihai S, Codrici E, Popescu ID, Enciu AM, Albulescu L, Necula LG, et al. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res. 2018;2018:2180373.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Stenvinkel P, Chertow GM, Devarajan P, Levin A, Andreoli SP, Bangalore S, et al. Chronic inflammation in chronic kidney disease progression: role of Nrf2. Kidney Int Rep. 2021;6(7):1775–87.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16(5):269–88.

    Article  PubMed  Google Scholar 

  25. Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26(1):8–15.

    Article  PubMed  Google Scholar 

  26. Bronze-da-Rocha E, Santos-Silva A. Neutrophil elastase inhibitors and chronic kidney disease. Int J Biol Sci. 2018;14(10):1343–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kim IS, Kim DH, Lee HW, Kim SG, Kim YK, Kim JK. Role of increased neutrophil extracellular trap formation on acute kidney injury in COVID-19 patients. Front Immunol. 2023;14:1122510.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Meijers RW, Betjes MG, Baan CC, Litjens NH. T-cell ageing in end-stage renal disease patients: assessment and clinical relevance. World J Nephrol. 2014;3(4):268–76.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Vicente R, Mausset-Bonnefont AL, Jorgensen C, Louis-Plence P, Brondello JM. Cellular senescence impact on immune cell fate and function. Aging Cell. 2016;15(3):400–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340(2):115–26.

    Article  CAS  PubMed  Google Scholar 

  31. De Miguel C, Guo C, Lund H, Feng D, Mattson DL. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. Am J Physiol Renal Physiol. 2011;300(3):F734–42.

    Article  PubMed  Google Scholar 

  32. Yoshitomi R, Nakayama M, Sakoh T, Fukui A, Katafuchi E, Seki M, et al. High neutrophil/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease. Ren Fail. 2019;41(1):238–43.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Xu B, Zhang Y, Chen G, Feng J, Gan L. Association of mean platelet volume/lymphocyte ratio with inflammation in non-dialysis patients with chronic kidney disease stages 1–4: a retrospective study. Front Immunol. 2022;13:1041356.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Cordeiro AC, Qureshi AR, Stenvinkel P, Heimbürger O, Axelsson J, Bárány P, et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant. 2010;25(2):562–8.

    Article  PubMed  Google Scholar 

  35. Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34(3):509–15.

    Article  CAS  PubMed  Google Scholar 

  36. Alkhatib L, Velez Diaz LA, Varma S, Chowdhary A, Bapat P, Pan H, et al. Lifestyle modifications and nutritional and therapeutic interventions in delaying the progression of chronic kidney disease: a review. Cureus. 2023;15(2): e34572.

    PubMed  PubMed Central  Google Scholar 

  37. Xiao L, Harrison DG. Inflammation in hypertension. Can J Cardiol. 2020;36(5):635–47.

    Article  PubMed  Google Scholar 

  38. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116(1):85–97.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr. Dachuan Guo, National Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodeling and Function Research, Department of Cardiology, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong University, for his guidance on the NHANES data weighting processing R code as well as methodology, and we thank Ying-Long Peng, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), School of Medicine, South China University of Technology, for guidance on this public database clinical study.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Peixian Huang: conceptualization; methodology; formal analysis; writing—original draft. Yanpei Mai: methodology; formal analysis; writing—original draft; writing—review and editing. Jun Zhao, Yushan Yi: formal analysis; writing—original draft. Yaqing Wen: data curation; writing—original draft.

Corresponding author

Correspondence to Yanpei Mai.

Ethics declarations

Conflict of interest

The authors declare that no relationships or activities might bias their work or be perceived as biased.

Ethical approval

The survey protocol for the NHANES was approved by CDC’s National Center for Health Statistics Institutional Research Ethics Review Board.

Consent for publication

We confirm that the manuscript has been read and approved for publication by all of the named authors, and that there are no other persons who meet the criteria for authorship but are not listed. We also confirm that the order of authorship listed in the manuscript has been approved by all of us.

Additional information

Responsible Editor: John Di Battista.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yanpei Mai is tagged as co-first author. Peixian Huang and Yanpei Mai share the first authorship and have equal status.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file 1 (DOCX 3936 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, P., Mai, Y., Zhao, J. et al. Association of systemic immune-inflammation index and systemic inflammation response index with chronic kidney disease: observational study of 40,937 adults. Inflamm. Res. 73, 655–667 (2024). https://doi.org/10.1007/s00011-024-01861-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-024-01861-0

Keywords

Navigation